VoiceMed-WomenTechEU
Financiado
MONITOR RESPIRATORY HEALTH USING VOICE
Voice can tell a lot of information about our health. We believe that voice is the new blood for medical diagnosis.
Asthma is a long-term disease that affects the lungs and airways. It is one of the most common chronic diseases w...
Voice can tell a lot of information about our health. We believe that voice is the new blood for medical diagnosis.
Asthma is a long-term disease that affects the lungs and airways. It is one of the most common chronic diseases with 5.8% of the EU population suffering from asthma - ~30 mill people. Doctors have always relied on the patient’s voice as one of the first parameters to assess health. When they talk to a patient, they carefully listen to their breathing, cough, and speech looking for specific signs. However, doctors usually evaluate patients without using any digital solution, leading to a 50% rate in non-well-controlled patients.
Deep-tech innovation: VoiceMed uses vocal biomarkers combined with sound analysis and artificial intelligence. Our technology detects subtle signals in the sounds produced by the vocal apparatus. When the association between a signal either a normal biological or pathogenic state is fully validated, these signals become vocal biomarkers. This process allows going beyond the sounds routinely used in medical practice, such as wheezes or crackles, and unlocking a new dimension of biomarkers that can be assessed remotely, instantaneously and with no extra equipment.
Women Founders:
Arianna Arienzo (CEO) - +6 years experience in business in 5 countries (including Silicon Valley). Entrepreneur in digital health and digital technologies. Listed in Forbes Under 30 in 2022. Contract professor at Cattolica university in healthcare innovation. Msc business administration.
Dr. Ayana de Brito (CSO) - +9 years’ experience as a research scientist in computational biology, currently leading our research team. She has skills in scientific practices, scientific writing, pm, strategic planning, data analysis, statistics, data visualization and programming. She is an expert also in regulatory affairs, with knowledge also in privacy. PhD in computational biologist.
ver más
Duración del proyecto: 12 meses
Fecha Inicio: 2023-05-31
Fecha Fin: 2024-06-30
Fecha Fin: 2024-06-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-06-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIE-2022-SCALEUP-02-02:
Women TechEU
Cerrada
hace 2 años
Presupuesto
El presupuesto total del proyecto asciende a
75K€
Líder del proyecto
VOICEMED SARL
No se ha especificado una descripción o un objeto social para esta compañía.
